CX3CL1 and obesity due to melanocortin 4 receptor deficiency: In the context of obesity, fractalkine has already been implicated in obesity-associated diseases such as diabetes and cardiovascular disease and in the chronic inflammation that precedes metabolic dysfunction; meta-inflammation (7, 8, 10, 14).